雅虎香港 搜尋

登入

  1. pfizer/biontech vaccine 相關

    廣告
  2. www.creative-biolabs.com/Vaccine/Technology

    Vaccine Development Platform - Technology of Creative Biolabs

    上個月有 超過 1 萬 名用戶曾瀏覽 creative-biolabs.com

    Specialized in Vaccine Design and Development. Custom Service Meet Your Needs. Comprehensive Vaccine Design&Manufacture Service. Learn more.

    View Services · Subscribe To Newsletter · Browse Products

    Types: In silico Vaccine Design、Subunit Vaccine Design、Cell Based Vaccines

  3. www.vaccines.hk/9價疫苗/十週年優惠

    【$1700】健苗網9價疫苗限時優惠 - 7*24自助預約 正貨加衛苗 - 可使用消費劵 任選全港20+服務點

    香港最具規模疫苗接種服務商之一。24週年醫療集團。有效預防90%由病毒引致的疾病，男女均需. 「健苗網」逾20個服務點遍及中環、銅鑼灣、尖沙咀、佐敦、旺角、荃灣、沙田、大埔、元朗、上水等

    gardasil9 · hvp預防注射計劃 · 全港20+服務點 · 7*24自助預約

搜尋結果

  1. www.pfizer.com › news › press-releasePfizer and BioNTech Receive U.S. FDA Approval & ...

    2024年8月22日 · Individuals 5 years of age and older with certain kinds of immunocompromise previously vaccinated with Pfizer and BioNTech COVID-19 vaccines or children under the age of 5 who have not already completed a three-dose series with previous formulas of a COVID-19 vaccine may be eligible to receive additional doses.

  2. www.pfizer.com › news › press-releasePfizer and BioNTech Provide Update on mRNA-based Combination ...

    2024年8月16日 · NEW YORK & MAINZ, Germany-- (BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE, “Pfizer”) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) today announced top-line results from their Phase 3 clinical trial to evaluate the companies’ combined mRNA vaccine candidate against influenza and COVID-19 in healthy individuals 18-64 years of age.

  3. 影片

    查看全部

  4. www.fda.gov › news-events › press-announcementsFDA Approves and Authorizes Updated mRNA COVID-19 Vaccines ...

    2024年8月22日 · Unvaccinated individuals 6 months through 4 years of age are eligible to receive three doses of the updated, authorized Pfizer-BioNTech COVID-19 Vaccine or two doses of the updated, authorized...

  5. hk.finance.yahoo.com › news › pfizer-biontech-receive-u-fdaPfizer and BioNTech Receive U.S. FDA Approval & ...

    2024年8月22日 · Pfizer-BioNTech COVID-19 Vaccine (2024-2025 Formula)* is FDA authorized under Emergency Use Authorization (EUA) to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory...

  6. www.yalemedicine.org › news › covid-19-vaccine-comparisonComparing the COVID-19 Vaccines: How Are They Different?

    3 天前 · The Pfizer-BioNTech vaccine (brand name: Comirnaty) was granted full Food and Drug Administration (FDA) approval in August 2021 for people ages 16 and older. Before that, it was the first COVID vaccine to receive FDA Emergency Use Authorization (EUA) back in December 2020, after the company reported that its vaccine was highly ...

    • kathy.katella-cofrancesco@yale.edu

  7. 焦點新聞

    查看全部

  8. www.businesswire.com › news › homePfizer and BioNTech Receive U.S. FDA Approval & ...

    2024年8月22日 · Individuals 5 years of age and older with certain kinds of immunocompromise previously vaccinated with Pfizer and BioNTech COVID-19 vaccines or children under the age of 5 who have not...

  9. finance.yahoo.com › news › pfizer-biontech-mrna-basedPfizer and BioNTech Provide Update on mRNA-based Combination ...

    2024年8月16日 · Story continues. NEW YORK & MAINZ, Germany, August 16, 2024--Pfizer Inc. (NYSE: PFE, "Pfizer") and BioNTech SE (Nasdaq: BNTX, "BioNTech") today announced top-line results from their Phase 3...